Get complete Patent Opposition Report for Neurodyn Life Sciences

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Neurodyn Life Sciences's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3009143Oct 3, 2018Progranulin For Use In Treating Parkinson'S Disease Or Alzheimer'S Disease2